$AMGN AMGEN INC Insider Trading
Get free email notifications about insider trading in AMGEN INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AMGEN INC. Insider overview, share value development, latest insider transactions and email notifications about new events in AMGEN INC for free.
CIK Number: 0000318154
IRS Number: 953540776
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) 
Trading Symbol: AMGN
Company Address: ONE AMGEN CENTER DRIVE THOUSAND OAKS 91320
Phone number: (805) 447-1000
Former name: AMGEN, date of change: 1987-03-05
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Market Capitalization: $124.07B
Prev close: $166.82
Average Daily Volume: 3,895,330
Days Low: $166.32
Year Low: $133.64
Year High: $176.85
AMGEN INC Latest Insider Transactions
|Date||Ticker||Company||Owner||Relationship||Transaction||Code||Cost ($)||Shares||Transaction Value ($)||Total Shares||% Holdings|
|May 19 2021||AMGN||AMGEN INC||MILES AMY E||Director||Grant||A||0.00||837||0||1,245||408 to 1.2 K (+205.15 %)|
|May 19 2021||AMGN||AMGEN INC||Kullman Ellen Jamison||Director||Grant||A||0.00||837||0||7,931||7.1 K to 7.9 K (+11.80 %)|
|May 19 2021||AMGN||AMGEN INC||Jacks Tyler||Director||Grant||A||0.00||837||0||12,410||11.6 K to 12.4 K (+7.23 %)|
|May 19 2021||AMGN||AMGEN INC||HOLLEY CHARLES M||Director||Grant||A||0.00||837||0||5,093||4.3 K to 5.1 K (+19.67 %)|
|May 12 2021||AMGN||AMGEN INC||SUGAR RONALD D||Director||Option Exercise||M||71.64||1,000||71,640||0|
|May 12 2021||AMGN||AMGEN INC||SUGAR RONALD D||Director||Sell||S||250.59||1,000||250,590||15,927||16.9 K to 15.9 K (-5.91 %)|
|May 12 2021||AMGN||AMGEN INC||SUGAR RONALD D||Director||Buy||M||71.64||1,000||71,640||16,927||15.9 K to 16.9 K (+6.28 %)|
|May 12 2021||AMGN||AMGEN INC||Grygiel Nancy A.||SVP & CCO||Option Exercise||M||162.60||2,500||406,500||1,639|
|May 12 2021||AMGN||AMGEN INC||Grygiel Nancy A.||SVP & CCO||Sell||S||252.51||2,500||631,272||12,461||15 K to 12.5 K (-16.71 %)|
|May 12 2021||AMGN||AMGEN INC||Grygiel Nancy A.||SVP & CCO||Buy||M||162.60||2,500||406,500||14,961||12.5 K to 15 K (+20.06 %)|
|May 10 2021||AMGN||AMGEN INC||Williams R Sanders||Director||Sell||S||251.78||250||62,945||4,409||4.7 K to 4.4 K (-5.37 %)|
|May 04 2021||AMGN||AMGEN INC||Santos Esteban||EVP, Operations||Option Exercise||A||239.64||34,420||8,248,409||34,420|
|May 04 2021||AMGN||AMGEN INC||Santos Esteban||EVP, Operations||Payment of Exercise||F||239.64||685||164,153||51,108||51.8 K to 51.1 K (-1.32 %)|
|May 04 2021||AMGN||AMGEN INC||Santos Esteban||EVP, Operations||Payment of Exercise||F||239.64||651||156,006||51,793||52.4 K to 51.8 K (-1.24 %)|
|May 04 2021||AMGN||AMGEN INC||Santos Esteban||EVP, Operations||Grant||A||0.00||3,964||0||52,444||48.5 K to 52.4 K (+8.18 %)|